Buzz
While the hope for a vaccine or groundbreaking treatment for COVID-19 persists, such breakthroughs won't be immediately evident from a news story that dominates your TV screen or social media. Many studies appear significant at first glance, but most end up being underwhelming once the full details are revealed.
Here are some key questions to consider when evaluating the significance of a new development:
What were the specific results or outcomes of the study?
Headlines often exaggerate to grab attention, but it's crucial to dive into the article and ask: what were the actual findings?
The article clarifies that the drug lowered the death rate from 41% to 28% for ventilator-dependent patients and from 25% to 20% for those requiring oxygen but not ventilators.
While the headline is technically correct in stating lives were saved, it’s not a universal cure, doesn’t work for all patients, and only benefits those in critical condition. Did the headline convey this nuance to you initially?
What is the scientific community’s opinion on this?
With science advancing rapidly, not all studies hold up under examination. Some COVID-19 research has been poorly conducted, overstated its claims, or relied on questionable data that couldn’t be validated.
Issues with a study often don’t surface immediately. It typically takes several days of scientific scrutiny and debate before flaws are identified. (Peer review, where experts evaluate a paper before publication, aims to address this early, but it doesn’t ensure perfection.)
I’ve learned to approach new studies or announcements with skepticism. As a reader, check if the reporter has consulted independent scientists who reviewed the study but weren’t part of its creation. If all quotes come from the study’s authors, remain cautious until further insights emerge.
Has the complete study been made public?
Anyone can claim exciting results to a reporter. However, if the findings are scientifically valid, the full study should be accessible. During COVID-19, many results were announced via press releases or conferences without publishing detailed methods or supporting data.
Researchers have an ethical duty to act swiftly if a treatment proves highly dangerous or life-saving. Ending a trial early or sharing critical findings promptly can save lives and should not be delayed.
However, there’s a flip side to this issue: what if the study is flawed or the findings are incomplete? It’s essential for other scientists to review the study to assess its validity and identify potential limitations. Announcing results without sharing data hampers the scientific community’s ability to evaluate and build on the research.
What happens next?
If a groundbreaking treatment for the coronavirus is discovered, it won’t fade away after a single news report. The findings will be validated through additional trials, and experts will provide ongoing feedback. The story will resurface repeatedly as the scientific process unfolds.
Keep in mind, numerous drugs and vaccines are under development, and it will take considerable time to determine their effectiveness. It’s more plausible that several treatments will offer modest benefits rather than a single miracle cure. Don’t focus on one story; consider how the new information aligns with existing knowledge and stay tuned for further updates.
